Skip to main content
. 2023 Nov 10;15(11):2241. doi: 10.3390/v15112241

Figure 4.

Figure 4

Comparison between lamivudine vs. control for acute hepatitis B virus infection. Outcome: Seroconversion to negative of HBsAg [20,21,22,23,24].